52.13
price up icon0.04%   0.02
after-market アフターアワーズ: 53.00 0.87 +1.67%
loading
前日終値:
$52.11
開ける:
$51.8
24時間の取引高:
1.02M
Relative Volume:
0.83
時価総額:
$4.13B
収益:
$900.66M
当期純損益:
$-453.20M
株価収益率:
-8.7761
EPS:
-5.94
ネットキャッシュフロー:
$-274.19M
1週間 パフォーマンス:
+16.52%
1か月 パフォーマンス:
+7.29%
6か月 パフォーマンス:
+13.62%
1年 パフォーマンス:
+59.47%
1日の値動き範囲:
Value
$50.67
$52.40
1週間の範囲:
Value
$44.15
$52.70
52週間の値動き範囲:
Value
$29.02
$58.38

Ptc Therapeutics Inc Stock (PTCT) Company Profile

Name
名前
Ptc Therapeutics Inc
Name
セクター
Healthcare (1164)
Name
電話
(908) 222-7000
Name
住所
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ
Name
職員
939
Name
Twitter
@PTCBio
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
PTCT's Discussions on Twitter

PTCT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PTCT
Ptc Therapeutics Inc
52.13 4.13B 900.66M -453.20M -274.19M -5.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Ptc Therapeutics Inc Stock (PTCT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-17 開始されました Truist Buy
2025-05-09 アップグレード BofA Securities Neutral → Buy
2025-05-07 アップグレード Citigroup Sell → Neutral
2025-03-11 アップグレード BofA Securities Underperform → Neutral
2025-03-07 開始されました Scotiabank Sector Perform
2024-12-13 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-03 アップグレード RBC Capital Mkts Sector Perform → Outperform
2024-10-10 再開されました Raymond James Mkt Perform
2024-09-04 開始されました Robert W. Baird Outperform
2024-08-26 再開されました UBS Buy
2024-05-20 アップグレード Raymond James Underperform → Mkt Perform
2023-12-19 ダウングレード Morgan Stanley Equal-Weight → Underweight
2023-12-08 開始されました Wells Fargo Overweight
2023-10-30 アップグレード Oppenheimer Perform → Outperform
2023-10-27 ダウングレード Citigroup Neutral → Sell
2023-10-06 ダウングレード Truist Buy → Hold
2023-09-18 ダウングレード Citigroup Buy → Neutral
2023-09-15 ダウングレード Raymond James Outperform → Underperform
2023-03-17 開始されました SVB Securities Market Perform
2022-12-14 開始されました Goldman Sell
2022-09-12 開始されました Jefferies Buy
2022-09-09 開始されました Morgan Stanley Equal-Weight
2022-09-01 開始されました Citigroup Buy
2022-04-04 再開されました Cantor Fitzgerald Overweight
2021-10-18 ダウングレード BofA Securities Neutral → Underperform
2021-04-26 再開されました Credit Suisse Neutral
2021-03-29 アップグレード RBC Capital Mkts Underperform → Sector Perform
2021-02-12 ダウングレード BofA Securities Buy → Neutral
2021-01-05 アップグレード Citigroup Neutral → Buy
2020-11-30 ダウングレード RBC Capital Mkts Sector Perform → Underperform
2020-10-30 ダウングレード Citigroup Buy → Neutral
2020-10-28 開始されました UBS Neutral
2020-10-07 アップグレード JP Morgan Neutral → Overweight
2020-08-25 開始されました Raymond James Outperform
2020-04-09 アップグレード Citigroup Neutral → Buy
2020-02-20 ダウングレード Citigroup Buy → Neutral
2020-02-20 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2019-11-12 開始されました SunTrust Buy
2019-05-13 アップグレード BofA/Merrill Neutral → Buy
2019-04-11 開始されました Bernstein Outperform
2018-10-03 アップグレード BofA/Merrill Underperform → Neutral
2018-10-01 開始されました Cantor Fitzgerald Overweight
2018-07-19 開始されました Credit Suisse Outperform
2018-06-18 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-04-04 ダウングレード Barclays Equal Weight → Underweight
2018-01-29 再開されました RBC Capital Mkts Sector Perform
2017-11-16 アップグレード JP Morgan Underweight → Neutral
2017-10-26 ダウングレード BofA/Merrill Neutral → Underperform
2017-10-09 ダウングレード JP Morgan Neutral → Underweight
すべてを表示

Ptc Therapeutics Inc (PTCT) 最新ニュース

pulisher
03:36 AM

William Blair Lowers Earnings Estimates for PTC Therapeutics - MarketBeat

03:36 AM
pulisher
02:53 AM

What institutional investors are buying PTC Therapeutics Inc. stockAchieve rapid wealth accumulation through smart investing - jammulinksnews.com

02:53 AM
pulisher
02:12 AM

Should I hold or sell PTC Therapeutics Inc. stock in 2025Get ahead with breakthrough trading ideas - jammulinksnews.com

02:12 AM
pulisher
02:11 AM

PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Acquired by XTX Topco Ltd - MarketBeat

02:11 AM
pulisher
01:42 AM

Is PTC Therapeutics Inc. a good long term investmentCapitalize on momentum-driven opportunities - jammulinksnews.com

01:42 AM
pulisher
10:56 AM

What drives PTC Therapeutics Inc. stock priceInvest confidently with professional market insights - jammulinksnews.com

10:56 AM
pulisher
07:48 AM

What are the latest earnings results for PTC Therapeutics Inc.Exponentially increasing returns - jammulinksnews.com

07:48 AM
pulisher
07:46 AM

How does PTC Therapeutics Inc. compare to its industry peersAchieve breakthrough financial results - jammulinksnews.com

07:46 AM
pulisher
06:53 AM

Is it the right time to buy PTC Therapeutics Inc. stockTake advantage of unprecedented market momentum - jammulinksnews.com

06:53 AM
pulisher
03:53 AM

What makes PTC Therapeutics Inc. stock price move sharplyIdentify winners with top-tier analysis - jammulinksnews.com

03:53 AM
pulisher
02:15 AM

What is the risk reward ratio of investing in PTC Therapeutics Inc. stockInvest with confidence backed by data - jammulinksnews.com

02:15 AM
pulisher
01:29 AM

Why is PTC Therapeutics Inc. stock attracting strong analyst attentionExceptional profit velocity - jammulinksnews.com

01:29 AM
pulisher
Aug 02, 2025

PTC Therapeutics (NASDAQ:PTCT) Shares Gap Up After Analyst Upgrade - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

How does PTC Therapeutics Inc. generate profit in a changing economyBuild a diversified portfolio for risk management - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

What are PTC Therapeutics Inc. company’s key revenue driversGet expert insights on market-moving stocks - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

Bank of America Forecasts Strong Price Appreciation for PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

PTC Therapeutics (NASDAQ:PTCT) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Bayforest Capital Ltd Takes $415,000 Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Q3 Earnings Estimate for PTCT Issued By William Blair - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $46.00 at Barclays - MarketBeat

Aug 02, 2025
pulisher
Aug 01, 2025

Truist Financial Issues Positive Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

PTC Therapeutics (PTCT) to Release Quarterly Earnings on Thursday - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

Is PTC Therapeutics Inc. a growth stock or a value stockChart Pattern Tips For Beginners - jammulinksnews.com

Aug 01, 2025
pulisher
Jul 31, 2025

Q3 EPS Forecast for PTC Therapeutics Decreased by Analyst - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

PTC Therapeutics: Uncertainty Abounds Ahead Of Q2 EarningsI'm Upgrading To 'Hold' - Seeking Alpha

Jul 31, 2025
pulisher
Jul 31, 2025

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance

Jul 31, 2025
pulisher
Jul 31, 2025

PTC Therapeutics shares rise 1.57% premarket after expanding collaboration with NVIDIA for AI development. - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Y Intercept Hong Kong Ltd Sells 6,043 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jul 31, 2025
pulisher
Jul 31, 2025

Using data models to predict PTC Therapeutics Inc. stock movementSwing Entry Insight With Forecast Accuracy - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval - BioPharma Dive

Jul 30, 2025
pulisher
Jul 30, 2025

Wells Fargo & Company Issues Positive Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price - MarketBeat

Jul 30, 2025
pulisher
Jul 30, 2025

PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $120.00 at Cantor Fitzgerald - MarketBeat

Jul 30, 2025
pulisher
Jul 30, 2025

PTC Therapeutics (PTCT) Surges 11.2%: Is This an Indication of Further Gains? - Nasdaq

Jul 30, 2025
pulisher
Jul 30, 2025

A Quick Look at Today's Ratings for PTC Therapeutics(PTCT.US), With a Forecast Between $46 to $120 - 富途牛牛

Jul 30, 2025
pulisher
Jul 30, 2025

Orsini Selected as Specialty Pharmacy Partner for PTC Therapeutics' SEPHIENCE™ (sepiapterin) - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

36,246 Shares in PTC Therapeutics, Inc. (NASDAQ:PTCT) Purchased by Neo Ivy Capital Management - MarketBeat

Jul 30, 2025
pulisher
Jul 30, 2025

Price Reversal in PTC Therapeutics Inc. Traders Watch CloselyBuy Low Sell High Stock Watch Strategy in Focus - beatles.ru

Jul 30, 2025
pulisher
Jul 29, 2025

AI Tools Suggest PTC Therapeutics Inc. May Outperform This WeekSecure Return Focused Investment Plan Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

PTC Therapeutics Inc. Breakout Confirmed by Volume MetricsBreakout Momentum Picks With Protection Outlined - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

PTC To Challenge BioMarin In PKU With Oral Sephience - insights.citeline.com

Jul 29, 2025
pulisher
Jul 29, 2025

PTC Therapeutics (NASDAQ:PTCT) Shareholders Are Still up 36% Over 1 Year Despite Pulling Back 7.4% in the Past Week - 富途牛牛

Jul 29, 2025
pulisher
Jul 29, 2025

PTCT’s Future: A Game Changer? - StocksToTrade

Jul 29, 2025
pulisher
Jul 29, 2025

Why Is PTC Therapeutics Stock Trading Higher Today?PTC Therapeutics (NASDAQ:PTCT) - Benzinga

Jul 29, 2025
pulisher
Jul 29, 2025

PTC Therapeutics stock price target raised to $120 from $112 at Cantor Fitzgerald - Investing.com

Jul 29, 2025
pulisher
Jul 29, 2025

PTC Therapeutics stock jumps as Truist raises price target on Sephience approval - Investing.com Canada

Jul 29, 2025

Ptc Therapeutics Inc (PTCT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):